We are executive search and leadership development specialists working to build a better future. As advisors and consultants to companies at the cutting edge of Health, Science, and Technology, we are united by our mission to build teams that change the world. Operating uniquely as one global team, we have honed our expertise, platform, and data for over two decades, working across three continents, and in 40 countries. Applying what we learn through our work with boards, leadership teams, and investors in the world’s most innovative companies, we bring together and develop the right people at the right time to propel them to achieve their worthwhile goals.
The Coulter Partners team is made up of 110 experts, working in 40 countries, holding 250,000 conversations with industry leaders each year. Together we channel data and learning to the benefit of our clients. We are a diverse group of experts with backgrounds ranging from science and technology, to the arts, finance, and more. Our reward system is designed to drive one-team behaviors and we work together seamlessly to combine industry experience and global insight with our passion for progress. Our team understands and is up to date with the challenges you face and the opportunities your business can maximize. This means we can find and develop exceptional individuals to drive you forward.
Our network is carefully curated and gives us access to leaders who can guide science, technology and innovation-driven companies through all stages of growth and evolution. Our executive search is an end-to-end process, underpinned by rigorous data and analytics from our dedicated Business Intelligence function and CP:Net™, our proprietary AI-driven candidate and company database. Our Board Advisory brings over two decades’ experience in building, advising and evolving boards for private and public companies. We understand what value a board can bring and how to evaluate its suitability for the stage of the business and the 3–5-year plan. We also provide leadership advisory at every step of the way. We have a network of mentors and advisors that bring the next level of insight to your organization, to build teams that change the world.
Life sciences-focused executive search firm Coulter Partners placed Khaled Bahi as the new CFO of Paris-based Stilla Technologies. Client partner Eskil Westh led the assignment. Mr. Bahi’s appointment comes at a time of rapid growth for the company, with the recent opening of a U.S. subsidiary headquartered in Beverly, MA, providing American customers with direct sales and
With the integration of technology into all facets of everyday life, the life sciences and healthcare industry is hardly alone in facing technology-related issues. These take on increased importance when they impact health, disease diagnosis, treatment and, ultimately, human longevity. Having the right leaders in place to sort through these complex challenges, say recruiters serving
Life sciences-focused executive search firm Coulter Partners has expanded with the opening of a new office in Brussels and six recent appointments. Penny Sadler joins the firm’s medtech expertise as client partner in Brussels, while Nanna Soni is appointed director in London to the R&D center of expertise. The Paris office expands with the additions of Nicolas
Life sciences-focused executive search firm Coulter Partners has recruited Mark Sampson as chief scientific officer of Azitra, a clinical-stage medical dermatology company that combines the power of the microbiome with cutting-edge genetic engineering to treat skin disease. Recruiters Chris Palatucci, Nicholas Green and Natasha Bull led the assignment. “Mark brings insight, experience and focused leadership to our programs
Coulter Partners recently partnered with hC Bioscience and is pleased to announce the placements of Jose Lora, Ph.D. as Chief Scientific Officer (CSO), and Heather Hirsch, Ph.D. as SVP of Translational Science and Cancer Biology. hC Bioscience is a pioneering biotech company dedicated to advancing tRNA-based therapies, a new class of treatments that target disease-causing
24 August 2023 – Coulter Partners recently partnered with the Cell and Gene Therapy Catapult (CGT Catapult) announcing the placement of Jeanette Evans as Chief Business Officer (CBO), taking over from Sharon Brownlow, with effect in August 2023. CGT Catapult is an independent innovation and technology organisation committed to the advancement of cell and gene
Coulter Partners announces the placement of Michael Akoh, ArcticZymes’ new Chief Executive Officer. ArcticZymes Technologies ASA (OSE:AZT) is a Norwegian life sciences company focused on the development, manufacturing and commercialization of novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Commenting on his appointment at ArcticZymes Michael Akoh said: “I am delighted to
Coulter Partners recently announced the placements at Dalriada of Adam Davenport, Ph.D. as Chief Research & Development Officer (CRDO), and Frosty Loechel, Ph.D. as SVP Biology, Discovery Strategy group. Dalriada, through its TURN-KEY™ Drug Discovery services model, provides a full suite of drug discovery, medicinal chemistry, and intellectual property services for semi-virtual, lean biotechnology clients
Coulter Partners is pleased to announce the placement of Gerben van ‘t Klooster as Chief Development Officer (CDO) of TargED Biopharmaceuticals. TargED is a biotechnology company dedicated to the development of innovative therapies for rare diseases that develops first-in-class biological drugs to improve the treatment of thrombosis. Gerben van ‘t Klooster, Ph.D. is a seasoned
News
Top hires for Q3-2025
Top hires for Q2-2025
Coulter Partners: Fostering Digital Health connections on the Seine
Coulter Partners at BIA Women in Biotech: Driving diversity in Life Sciences leadership
Coulter Partners joins key discussion on HealthTech Boards at NHS Innovation Accelerator day
Coulter Partners at the BIA Life Science Leadership Summit: Fostering Board Excellence and UK Biotech Growth!
Coulter Partners attends LabCentral’s Luminescence: Rise & Fund event in Boston, MA
Leadership in MedTech: Key insights from our Paris roundtable
Coulter Partners co-hosts premier UK HealthTech Super Connector event
Coulter Partners attends Bio€quity Europe in Bruges, Belgium
Coulter Partners attends Danish Biotech Spring Gala
Top hires for VC & PE portfolio companies Q1-2025
Evolution Italy: Life Science leaders gather for insightful discussions
Coulter Partners at BioCapital Europe 2025: Innovation and optimism reign
BioInnovation Institute Breakfast Seminar Health Tech Ecosystem – Copenhagen
BIA Gala Dinner 2025
Top hires for VC & PE portfolio companies Q4-2024
Top global hires for large-cap, mid-cap and public companies H2-2024